EUROPEAN MARKETS FOR PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY AND CORONARY STENTING PRODUCTS

373 Pages | 89 Exhibits | 2010 Analysis | Forecasts Through 2014 Product Family: Market Reports




OVERVIEW:
Coronary heart disease (CHD) is responsible for more than 1.9 million deaths in Europe each year, accounting for 21.0% of deaths in men and 22.2% of deaths in women. In the 27 member countries comprising the European Union (EU), CHD accounts for approximately 741,833 deaths annually, with 16.0% and 14.8% of deaths in men and women attributable to the disease, respectively. The morbidity and mortality rates associated with CHD continue to fuel the demand for percutaneous transluminal coronary angioplasty (PTCA) and coronary stenting products-particularly drug-eluting stents-to treat advanced cases that cannot be adequately managed with lifestyle changes or aggressive medical therapy.

Approximately 800,000 PTCA and/or coronary stenting procedures were performed in Europe in 2009, generating nearly $1.9 billion in corresponding product sales. It is expected that during the forecast period, sales of PTCA and coronary stenting products will increase at a compound annual rate of 5.1%, reaching an estimated $2.4 billion in the year 2014.

This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities for suppliers of PTCA and coronary stenting products in Europe.

Covered topics in this report include bare-metal and drug-eluting stent systems; conventional and drug-eluting balloon angioplasty procedures; conventional balloon angioplasty catheters; coronary stenting procedures; drug-eluting balloon angioplasty catheters; guidewires; guiding catheters; national healthcare systems in France, Germany, Italy, Spain, the United Kingdom and the Benelux countries of Belgium, Luxembourg, and the Netherlands; European heart disease and population statistics; introducers/sheaths; inflation devices; stent coatings and surfaces and anti-restenosis agents; stent configurations and materials; technological developments in coronary angioplasty and stenting; and vascular access site closure devices.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Percutaneous Transluminal Coronary Angioplasty Devices Market
	a. Products
		i. Balloon Angioplasty Catheters
		ii. Guiding Catheters
		iii. Guidewires
		iv. Introducers/Sheaths
		v. Inflation Devices
		vi. Vascular Access Site Closure Devices
	b. Market Forecast
ii. Coronary Stenting Systems Market
	a. Products
	b. Market Forecast
iii. Methodology

Exhibit ES-1: Europe, Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting, Procedure Volumes Forecast, by Country, 2009-2014
Exhibit ES-2: Europe, Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Systems, Market Forecast, by Country, 2009-2014
Exhibit ES-3: Europe, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit ES-4: France, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit ES-5: Germany, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit ES-6: Italy, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit ES-7: Spain, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit ES-8: United Kingdom, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit ES-9: Benelux Countries, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit ES-10: Europe, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit ES-11: France, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit ES-12: Germany, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit ES-13: Italy, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit ES-14: Spain, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit ES-15: United Kingdom, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit ES-16: Benelux Countries, Coronary Stents, Combined Market Forecast, 2009-2014

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union
	1.1.1 A Common Currency
	1.1.2 Regulatory Policies
	1.1.3 Reimbursement
	1.1.4 Healthcare Spending
1.2 Selected European National Healthcare Profiles
	1.2.1 France
		1.2.1.1 Healthcare Organization and Reform
		1.2.1.2 Hospital Services
		1.2.1.3 Medical Device Reimbursement
	1.2.2 Germany
		1.2.2.1 Healthcare Organization and Reform
		1.2.2.2 Hospital Services
		1.2.2.3 Medical Device Reimbursement
	1.2.3 Italy
		1.2.3.1 Healthcare Organization and Reform
		1.2.3.2 Hospital Services
		1.2.3.3 Medical Device Reimbursement
	1.2.4 Spain
		1.2.4.1 Healthcare Organization and Reform
		1.2.4.2 Hospital Services
		1.2.4.3 Medical Device Reimbursement
	1.2.5 United Kingdom
		1.2.5.1 Healthcare Organization and Reform
		1.2.5.2 Hospital Services
		1.2.5.3 Medical Device Reimbursement
	1.2.6 Benelux
		1.2.6.1 Healthcare Organization and Reform
			1.2.6.1.1 Belgium
			1.2.6.1.2 Luxembourg
			1.2.6.1.3 The Netherlands
		1.2.6.2 Hospital Services
		1.2.6.3 Medical Device Reimbursement

Exhibit 1-1: European Union, Medical Devices Risk Classification System
Exhibit 1-2: European Union Population Statistics Comparison for the Years 1999, 2009, and 2019
Exhibit 1-3: France, Selected National Healthcare Statistics
Exhibit 1-4: Germany, Selected National Healthcare Statistics
Exhibit 1-5: Italy, Selected National Healthcare Statistics
Exhibit 1-6: Spain, Selected National Healthcare Statistics
Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics
Exhibit 1-8: Belgium, Selected National Healthcare Statistics
Exhibit 1-9: Luxembourg, Selected National Healthcare Statistics
Exhibit 1-10: The Netherlands, Selected National Healthcare Statistics

2. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

2.1 The Heart and Circulatory System
	2.1.1 The Cardiac Conduction Sytem
	2.1.2 The Heart Valves
2.2 Diseases/Disorders Involving the Vasculature
	2.2.1 Coronary Heart Disease
		2.2.1.1 Atherosclerosis
			2.2.1.1.1 Description
			2.2.1.1.2 Statistics
		2.2.1.2 Angina Pectoris
			2.2.1.2.1 Description
			2.2.1.2.2 Statistics
		2.2.1.3 Myocardial Infarction
			2.2.1.3.1 Description
			2.2.1.3.2 Statistics
	2.2.2 Hypertension
		2.2.2.1 Description
			2.2.2.1.1 Systolic and Diastolic Pressures
			2.2.2.1.2 Prehypertension
		2.2.2.2 Statistics
	2.2.3 Aneurysm
		2.2.3.1 Description
		2.2.3.2 Statistics
	2.2.4 Stroke
		2.2.4.1 Description
		2.2.4.2 Statistics
2.3 Diseases/Disorders Involving the Cardiac Conduction System
	2.3.1 Types
		2.3.1.1 Bradycardia
			2.3.1.1.1 Description
		2.3.1.2 Sick Sinus Syndrome
			2.3.1.2.1 Description
		2.3.1.3 Heart Block
			2.3.1.3.1 Description
		2.3.1.4 Atrial Fibrillation
			2.3.1.4.1 Description
		2.3.1.5 Tachycardia
			2.3.1.5.1 Description
		2.3.1.6 Ventricular Fibrillation
			2.3.1.6.1 Description
	2.3.2 Statistics
2.4 Diseases/Disorders Involving the Myocardium
	2.4.1 Heart Defects
		2.4.1.1 Description
		2.4.1.2 Statistics
	2.4.2 Heart Failure
		2.4.2.1 Description
		2.4.2.2 Statistics
	2.4.3 Rheumatic Fever/Rheumatic Heart Disease
		2.4.3.1 Description
		2.4.3.2 Statistics
	2.4.4 Heart Valve Disorders
		2.4.4.1 Types
			2.4.4.1.1 Valvular Stenosis
				2.4.4.1.1.1 Description
			2.4.4.1.2 Valvular Regurgitation
				2.4.4.1.2.1 Description
			2.4.4.1.3 Valve Prolapse
				2.4.4.1.3.1 Description
		2.4.4.2 Statistics

Exhibit 2-1: Cross-Section Diagram of the Heart
Exhibit 2-2: Cross-Section Diagram of the Heart Valves
Exhibit 2-3: Men, Number of Deaths due to Cardiovascular Disease, Selected European Countries
Exhibit 2-4: Women, Number of Deaths due to Cardiovascular Disease, Selected European Countries
Exhibit 2-5: Total Cholesterol Levels in Men, Selected European Countries, 2005 and 2010
Exhibit 2-6: Total Cholesterol Levels in Women, Selected European Countries, 2005 and 2010
Exhibit 2-7: Europe, Atherosclerosis Prevalence, by Country
Exhibit 2-8: Standard Angina Pectoris Classification
Exhibit 2-9: Europe, Coronary Events Incidence Rates, Selected MONICA Project Populations, by Gender Group
Exhibit 2-10: Europe, Myocardial Infarction Prevalence, by Country
Exhibit 2-11: Europe, Systolic Blood Pressure Levels, Selected MONICA Project Populations, by Gender Group
Exhibit 2-12: Mean Systolic Blood Pressure Levels in Men, Selected European Countries, 2005 and 2010
Exhibit 2-13: Mean Systolic Blood Pressure Levels in Women, Selected European Countries 2005 and 2010
Exhibit 2-14: Europe, Hypertension Prevalence, by Country
Exhibit 2-15: Europe, Aneurysm Prevalence, by Country
Exhibit 2-16: Europe, Stroke Disability and Mortality, By Country
Exhibit 2-17: Europe, Stroke Prevalence, by Country
Exhibit 2-18: Europe, Cardiac Dysrhythmia Prevalence, by Country
Exhibit 2-19: Congenital Heart Defects, Estimated Number of Simple and Complex Cases in the United Kingdom, 2000 and 2010
Exhibit 2-20: United Kingdom, Heart Failure Prevalence, Selected Study Data
Exhibit 2-21: Europe, Heart Failure Prevalence, by Country
Exhibit 2-22: Rheumatic Heart Disease, Estimated Number of Reported Cases, Selected Countries/Regions
Exhibit 2-23: Rheumatic Heart Disease Mortality, Selected European Countries
Exhibit 2-24: Euro Heart Survey on Valvular Heart Disease Patient Population, Native Heart Valve Disorders, by Type
Exhibit 2-25: Europe, Heart Valve Disorder Prevalence, by Country

3. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PRODUCTS MARKET

3.1 Percutaneous Transluminal Coronary Angioplasty
	3.1.1 Approaches
	3.1.2 Indications
	3.1.3 Complications/Efficacy
	3.1.4 Adjunctive Anti-Clotting Drug Therapies
	3.1.5 Conventional versus Drug-Eluting Balloon Angioplasty
	3.1.6 Products
		3.1.6.1 Balloon Angioplasty Catheters
			3.1.6.1.1 Conventional
			3.1.6.1.2 Drug-Eluting
		3.1.6.2 Guiding Catheters
		3.1.6.3 Guidewires
		3.1.6.4 Introducers/Sheaths
		3.1.6.5 Inflation Devices
		3.1.6.6 Vascular Access Site Closure Devices
	3.1.7 Procedure Volumes
	3.1.8 Market Forecast
	3.1.9 Competitors

Exhibit 3-1: 2010, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters
Exhibit 3-2: 2010, Selected Guiding Catheters
Exhibit 3-3: 2010, Selected Guidewires
Exhibit 3-4: 2010, Selected Introducers/Sheaths
Exhibit 3-5: 2010, Selected Inflation Devices
Exhibit 3-6: 2010, Selected Vascular Access Site Closure Devices
Exhibit 3-7: Europe, Percutaneous Transluminal Coronary Angioplasty/Coronary Stenting, Procedure Volumes Forecast, 2009-2014
Exhibit 3-8: France, Percutaneous Transluminal Coronary Angioplasty/ Coronary Stenting, Procedure Volumes Forecast,  2009-2014
Exhibit 3-9: Germany, Percutaneous Transluminal Coronary Angioplasty/ Coronary Stenting, Procedure Volumes Forecast,  2009-2014
Exhibit 3-10: Italy, Percutaneous Transluminal Coronary Angioplasty/ Coronary Stenting, Procedure Volumes Forecast,  2009-2014
Exhibit 3-11: Spain, Percutaneous Transluminal Coronary Angioplasty/ Coronary Stenting, Procedure Volumes Forecast,  2009-2014
Exhibit 3-12: United Kingdom, Percutaneous Transluminal Coronary Angioplasty/Coronary Stenting, Procedure Volumes Forecast, 2009-2014
Exhibit 3-13: Benelux Countries, Percutaneous Transluminal Coronary Angioplasty/Coronary Stenting, Procedure Volumes Forecast, 2009-2014
Exhibit 3-14: Europe, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit 3-15: France, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit 3-16: Germany, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit 3-17: Italy, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit 3-18: Spain, Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast, 2009-2014
Exhibit 3-19: United Kingdom, Percutaneous Transluminal Coronary Angioplasty Devices,  Market Forecast, 2009-2014
Exhibit 3-20: Benelux Countries, Percutaneous Transluminal Coronary Angioplasty Devices,  Market Forecast, 2009-2014
Exhibit 3-21: 2009, Percutaneous Transluminal Coronary Angioplasty Devices Market, Share by Supplier

4. CORONOARY STENT SYSTEMS MARKET

4.1 Coronary Stenting with Bare-Metal and Drug-Eluting Stents
	4.1.1 Stent Materials
		4.1.1.1 Cobalt-Based Alloys
		4.1.1.2 Nitinol
		4.1.1.3 Stainless Steel
		4.1.1.4 Tantalum
		4.1.1.5 Bioabsorbable Polymers and Metal-Based Alloys
	4.1.2 Stent Coatings/Surfaces and Anti-Restenosis Agents
	4.1.3 Stent Delivery/Deployment
	4.1.4 Indications
		4.1.4.1 Left Main Coronary Artery Disease
		4.1.4.2 Multivessel Coronary Artery Disease
	4.1.5 Complications/Efficacy
		4.1.5.1 Repeat Revascularization
		4.1.5.2 Stent Thrombosis
		4.1.5.3 Diabetes and Stenting
		4.1.5.4 Stenting-Associated ST-Segment Elevation Myocardial Infarction
	4.1.6 Products
	4.1.7 Procedure Volumes
	4.1.8 Market Forecast
	4.1.9 Competitors

Exhibit 4-1: 2010, Selected Anti-Restenosis Agents
Exhibit 4-2: 2010, Selected Coronary Stents
Exhibit 4-3: Europe, Coronary Stenting, Combined Procedure Volumes Forecast, 2009-2014
Exhibit 4-4: France, Coronary Stenting, Combined Procedure Volumes Forecast, 2009-2014
Exhibit 4-5: Germany, Coronary Stenting, Combined Procedure Volumes Forecast, 2009-2014
Exhibit 4-6: Italy, Coronary Stenting, Combined Procedure Volumes Forecast, 2009-2014
Exhibit 4-7: Spain, Coronary Stenting, Combined Procedure Volumes Forecast, 2009-2014
Exhibit 4-8: United Kingdom, Coronary Stenting, Combined Procedure Volumes Forecast, 2009-2014
Exhibit 4-9: Benelux Countries, Coronary Stenting, Combined Procedure Volumes Forecast, 2009-2014
Exhibit 4-10: Europe, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit 4-11: France, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit 4-12: Germany, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit 4-13: Italy, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit 4-14: Spain, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit 4-15: United Kingdom, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit 4-16: Benelux Countries, Coronary Stents, Combined Market Forecast, 2009-2014
Exhibit 4-17: 2009, Europe, Coronary Stent Systems Market, Share by Supplier

5. COMPANY PROFILES

5.1 Abbott Laboratories
5.2 B. Braun Melsungen AG
5.3 Biosensors International Group LTD
5.4 BIOTRONIK SE & Co, KG
5.5 Boston Scientific Corporation
5.6 Carbostent & Implantable Devices SRL
5.7 ClearStream Technologies Group PLC
5.8 Cook Group, Inc.
5.9 Cordis Corporation/Johnson & Johnson
5.10 eucatech AG
5.11 Hexacath
5.12 InSitu Technologies, Inc.
5.13 Medtronic, Inc.
5.14 Merit Medical Systems, Inc.
5.15 OrbusNeich
5.16 St. Jude Medical, Inc.
5.17 Terumo Medical Corporation/Terumo Corporation

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. Abbott Laboratories
  2. B. Braun Melsungen AG
  3. Biosensors International Group LTD
  4. BIOTRONIK SE & Co, KG
  5. Boston Scientific Corporation
  6. Carbostent & Implantable Devices SRL
  7. ClearStream Technologies Group PLC
  8. Cook Group, Inc.
  9. Cordis Corporation/Johnson & Johnson
  10. eucatech AG
  11. Hexacath
  12. InSitu Technologies, Inc.
  13. Medtronic, Inc.
  14. Merit Medical Systems, Inc.
  15. OrbusNeich
  16. St. Jude Medical, Inc.
  17. Terumo Medical Corporation/Terumo Corporation
Contact Us

Need help finding medtech research? Let us help you!